DETAR HEALTHCARE SYSTEMS
1. Target Overview & Investment Thesis
DETAR HEALTHCARE SYSTEMS is a 178-bed suburban community hospital in VICTORIA, TX with $216.8M in net patient revenue and a 13.0% operating margin. The hospital serves a payer mix of 25.1% Medicare, 6.7% Medicaid, and 68.3% commercial.
Thesis: Turnaround. Our ML models identify $16.0M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 13.0% to 20.3% (+736bps).
| Net Revenue HCRIS | $216.8M |
| Current EBITDA COMPUTED | $28.1M |
| Operating Margin COMPUTED | 13.0% |
| Occupancy HCRIS | 46.1% |
| Revenue / Bed COMPUTED | $1.2M |
| Net-to-Gross HCRIS | 11.0% |
| Distress Probability ML | 47.7% |
2. Market Context & Competitive Position
TX has 583 Medicare-certified hospitals with a median operating margin of -0.7%. The target's margin of 13.0% places it above the state median. Among 158 size-comparable peers (89-356 beds), the median margin is 3.3%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (89-356), prioritizing same-state peers. 158 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| DETAR HEALTHCARE SYSTEMS (Target) | TX | 178 | $216.8M | 13.0% |
| DELL CHILDRENS MEDICAL CENTER | TX | 262 | $901.9M | 25.5% |
| DRISCOLL CHILDRENS HOSPITAL | TX | 215 | $694.3M | 29.4% |
| ROUND ROCK HOSPITAL | TX | 165 | $681.4M | 8.7% |
| METHODIST SUGAR LAND HOSPITAL | TX | 337 | $679.6M | 12.6% |
| METHODIST WILLOWBROOK HOSPITAL | TX | 346 | $661.8M | 10.8% |
| GOOD SHEPHERD MEDICAL CENTER | TX | 314 | $557.4M | 0.7% |
| HOUSTON METHODIST THE WOODLAND | TX | 292 | $535.9M | 13.9% |
| METHODIST WEST HOUSTON HOSPITA | TX | 270 | $529.7M | 15.5% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $16.0M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $4.6M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $4.3M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $4.3M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $2.6M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $139K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $28.1M |
| + RCM Uplift | +$16.0M |
| Pro Forma EBITDA | $44.1M |
| Current Margin | 13.0% |
| Pro Forma Margin | 20.3% |
| WC Released (1x) | $8.3M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $43.2M | $344.9M | 7.98x | 51.5% |
| Base (11x exit) | 10.0x | 11.0x | $43.2M | $393.5M | 9.10x | 55.5% |
| Bull Case | 9.0x | 11.0x | $38.9M | $460.2M | 11.83x | 63.9% |
| Bull (12x exit) | 9.0x | 12.0x | $38.9M | $513.5M | 13.20x | 67.5% |
| Bear Case | 11.0x | 10.0x | $47.6M | $251.1M | 5.28x | 39.5% |
| Bear (11x exit) | 11.0x | 11.0x | $47.6M | $291.7M | 6.13x | 43.7% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Low | Low net-to-gross ratio | Large contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 158 hospitals with 89-356 beds
- Same-state prioritization (n=159)
- Comp margins: P25=-9.8% / P50=3.3% / P75=13.8%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.